ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Come To The Dark (Mode) Side

  Many of the decisions made by a product team start as suggestions from a user community of clinical professionals. While planning the development of a recently launched CTMS, a focus group was led where clinical professionals weighed in on potential improvements for a new system.

• The Strategic Role Of KOLs In Rare Disease Drug Development

  Engaging key Opinion Leaders (KOL) is crucial for accelerating rare disease research breakthroughs. However, identifying the right experts is challenging due to fragmented data and evolving expertise.

• AI In Clinical Trials: Key Insights From Industry Experts

  Find out what experts from the FDA are saying about AI’s ability to demonstrably impact three critical success metrics in clinical trials.

• Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch

  The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.

• Parkinson's Disease: Leveraging Wearable DHTs

  Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.

• Understanding Various Site Use Cases For eSource And EDC

  Learn how leveraging electronic data capture solutions can be pivotal in ensuring the successful execution of clinical research trials through expedited data processes, minimal errors, and more.

• Improving Patient Outcomes With Wearables In Major Depressive Disorder

  Learn how medical-grade wearable devices can help advance treatments in conditions like major depressive disorder and paint a more complete picture of patients with this often debilitating condition.

• Taking Advantage Of EMA CTR For eCOA Studies In EU

  Discover how sponsors can save time and effort by applying for clinical trial authorization once across the EU using the Clinical Trials Information System (CTIS).

• Rare Disease Clinical Trials: Modern Design And Supply Chain

  Gain insight from several contributing experts for overcoming unique obstacles in rare disease research and learn how to better develop strategies.

• One Day, We Won't Need Placebos

  Embrace the future of clinical research by recognizing the limitations of traditional double-blind trials and exploring the transformative potential of real-world evidence (RWE).